Clinical Trial Update: Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial update examines eszopiclone and inflammatory mediators in patients with acute coronary syndrome. Results were posted in December 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Insomnia

Drugs mentioned

• Eszopiclone (eszopiclone)

Snippet

Sponsor: University of Arizona | Conditions: Acute Coronary Syndrome, Sleep Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-12-20